Celltrion Pharm, Inc. (068760.KQ)
KRW 48000.0
(2.35%)
KRW 48000.0
(2.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.81 Billion | -9.22 Billion | 87.77 Billion | 30.61 Billion | 21.94 Billion | 8.59 Billion |
| Net Income | 21.26 Billion | 25.95 Billion | 34.57 Billion | 20.93 Billion | 8.6 Billion | -9.38 Billion |
| Depreciation & Amortization | 19.72 Billion | 17.41 Billion | 16.37 Billion | 13.46 Billion | 13.02 Billion | 12.71 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 2.69 Billion | 1.68 Billion | 1.49 Billion | 795.1 Million | - | - |
| Change in working capital | -40.97 Billion | -70.47 Billion | 25.87 Billion | -6.2 Billion | -8.36 Billion | -9.05 Billion |
| Other non-cash items | 85.29 Billion | 108.44 Billion | 36.99 Billion | 43.4 Billion | 42.23 Billion | 46.56 Billion |
| Investing Cash Flow | -5.53 Billion | -15.41 Billion | -16.52 Billion | -45.07 Billion | -34.51 Billion | -7.44 Billion |
| Investments in PPE | -6.89 Billion | -6.28 Billion | -12.5 Billion | -44.25 Billion | -32.05 Billion | -7.88 Billion |
| Acquisitions | - | 1.42 Million | - | 4.73 Million | 35.48 Million | 6.11 Million |
| Investment purchases | -54.46 Billion | -38.97 Billion | -20.97 Billion | -11 Billion | -2.56 Billion | -21 Million |
| Sales/Maturities of investments | 54.71 Billion | 29.97 Billion | 17 Billion | 10.36 Billion | - | 336 Million |
| Other Investing Activities | 1.1 Billion | -126.17 Million | -50.82 Million | -197.17 Million | 76.39 Million | 119.09 Million |
| Financing Cash Flow | -7.95 Billion | -24.15 Billion | -16.81 Billion | 29.45 Billion | 14.2 Billion | 2.31 Billion |
| Debt repayment | -2.08 Billion | -19.84 Billion | -11.91 Billion | -30.7 Billion | -14.33 Billion | -2.7 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -4.29 Billion | -4.57 Billion | -5.23 Billion | -1.1 Billion | - | -1.03 Billion |
| Common Stock Issuance | 553.75 Million | 853.92 Million | 925.31 Million | 264.11 Million | 254.81 Million | 643.31 Million |
| Other Financing Activities | -21.21 Million | -17 Million | -27 Million | 44 Million | 4.41 Billion | 4.39 Million |
| Accounts receivables | -34.89 Billion | -13.7 Billion | -31.68 Billion | -2.88 Billion | -5.99 Billion | -26.29 Billion |
| Accounts payables | 21.19 Billion | -34.12 Billion | 50.9 Billion | 14.8 Billion | -5.56 Billion | -792.2 Million |
| Inventory | -30.34 Billion | -7.9 Billion | -12.5 Billion | -25.97 Billion | 4.06 Billion | 20.27 Billion |
| Other working capital | 3.07 Billion | -14.74 Billion | 19.15 Billion | 7.85 Billion | -870.36 Million | -2.25 Billion |
| Cash at beginning of period | 31.39 Billion | 80.18 Billion | 25.74 Billion | 10.76 Billion | 9.11 Billion | 5.63 Billion |
| Cash at end of period | 19.71 Billion | 31.39 Billion | 80.18 Billion | 25.74 Billion | 10.76 Billion | 9.11 Billion |
| Capital Expenditure | -6.89 Billion | -6.28 Billion | -12.5 Billion | -44.25 Billion | -32.05 Billion | -7.88 Billion |
| Effect of forex changes on cash | -923.56 Thousand | -2.17 Million | 1.24 Million | -3.73 Million | 4.31 Million | 6772.99 |
| Net cash flow / Change in cash | -11.68 Billion | -48.79 Billion | 54.43 Billion | 14.98 Billion | 1.64 Billion | 3.47 Billion |
| Free Cash Flow | -5.08 Billion | -15.51 Billion | 75.27 Billion | -13.64 Billion | -10.1 Billion | 713.99 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.59 Billion | 1.89 Billion | 21.26 Billion | 709.08 Million | 3.3 Billion | 10.56 Billion |
| Depreciation & Amortization | 4.99 Billion | 5.13 Billion | 19.72 Billion | 5.23 Billion | 5.25 Billion | 4.86 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 404.51 Million | 2.69 Billion | 714.36 Million | 807.28 Million | 798.66 Million |
| Change in working capital | -25.56 Billion | 8.55 Billion | -40.97 Billion | 18.74 Billion | -39.18 Billion | -16.07 Billion |
| Other non-cash items | 38.42 Billion | -3.29 Billion | 85.29 Billion | -6.33 Billion | 51.21 Billion | 33.87 Billion |
| Investing Cash Flow | -7.03 Billion | -2 Billion | -5.53 Billion | -1.73 Billion | 1.39 Billion | -6.3 Billion |
| Investments in PPE | -1.6 Billion | -996.05 Million | -6.89 Billion | -1.76 Billion | -2.16 Billion | -2.37 Billion |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -17.97 Billion | -10 Billion | -54.46 Billion | -12.5 Billion | -19.95 Billion | -16 Billion |
| Sales/Maturities of investments | 12.47 Billion | 9 Billion | 54.71 Billion | 12.53 Billion | 22.95 Billion | 11.52 Billion |
| Other Investing Activities | 65 Million | -10 Million | 1.1 Billion | -10.00 | 565.29 Million | 547.66 Million |
| Financing Cash Flow | 3.15 Billion | -5.39 Billion | -7.95 Billion | -14.57 Billion | 9.93 Billion | 880.98 Million |
| Debt repayment | -9.66 Billion | -4.81 Billion | -2.08 Billion | -13.84 Billion | -10.66 Billion | -5.2 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -4.92 Billion | - | -4.29 Billion | - | - | -4.29 Billion |
| Common Stock Issuance | 385.71 Million | 161.22 Million | 553.75 Million | -10.00 | 14.7 Million | 473.56 Million |
| Other Financing Activities | -1.22 Billion | -1.4 Million | -21.21 Million | -20.00 | -852.99 Thousand | -14.3 Million |
| Accounts receivables | -4.62 Billion | 23.4 Billion | -34.89 Billion | 13.95 Billion | -33.26 Billion | -15.32 Billion |
| Accounts payables | -4.17 Billion | 2.76 Billion | 21.19 Billion | 11.37 Billion | 5.73 Billion | -17.21 Billion |
| Inventory | -17.87 Billion | -11.12 Billion | -30.34 Billion | -6.09 Billion | -13.13 Billion | 9.86 Billion |
| Other working capital | 1.11 Billion | -6.48 Billion | 3.07 Billion | -494.86 Million | 1.48 Billion | 6.59 Billion |
| Cash at beginning of period | 29.35 Billion | 19.71 Billion | 31.39 Billion | 8.9 Billion | 28.16 Billion | 32.75 Billion |
| Cash at end of period | 12.24 Billion | 29.35 Billion | 19.71 Billion | 19.71 Billion | 8.9 Billion | 28.16 Billion |
| Capital Expenditure | -1.6 Billion | -996.05 Million | -6.89 Billion | -1.76 Billion | -2.16 Billion | -2.37 Billion |
| Effect of forex changes on cash | - | 414.34 Thousand | -923.56 Thousand | -2.29 Million | -2.06 Million | 968.3 Thousand |
| Net cash flow / Change in cash | -17.11 Billion | 9.64 Billion | -11.68 Billion | 10.8 Billion | -19.26 Billion | -4.59 Billion |
| Free Cash Flow | -14.83 Billion | 16.04 Billion | -5.08 Billion | 25.35 Billion | -32.75 Billion | -1.54 Billion |
B52
603196
RRR
FMCCI
FLXI
PPG